Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Antimicrobial Resistance (AMR) Genotyping Panels Market Forecast: What Market Value Is Expected By 2030?
The market for antimicrobial resistance (AMR) genotyping panels has experienced a significant surge, projecting an expansion from $1.45 billion in 2025 to $1.66 billion in 2026, fueled by a compound annual growth rate (CAGR) of 14.4%. This robust growth trajectory observed historically is propelled by several key factors, including the escalating incidence of antimicrobial resistance, a rise in hospital-acquired infections, the broadening reach of molecular diagnostic technologies, heightened consciousness regarding resistance surveillance, and the ongoing development of sophisticated genotyping techniques.
The market for antimicrobial resistance (AMR) genotyping panels is poised for substantial expansion in the coming years, projected to reach a value of $2.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.1%. This anticipated growth is undergirded by several key factors, including heightened financial commitments to diagnosing infectious diseases, a burgeoning desire for swift point-of-care diagnostic solutions, the proliferation of genomic epidemiology initiatives, greater incorporation of AMR data analysis, and an escalating regulatory emphasis on monitoring resistance patterns. Key developments expected during this forecast period involve a greater embrace of panels capable of detecting multiple resistance markers simultaneously, augmented utilization of prompt molecular diagnostic methods, increased embedding of genomic surveillance technologies, broader implementation of AMR testing within hospital settings, and a reinforced drive toward identifying resistance at earlier stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30196&type=smp
Antimicrobial Resistance (AMR) Genotyping Panels Market Expansion Drivers: What Is Shaping Future Growth?
The increasing incidence of infections that are resistant to antimicrobial treatments is anticipated to drive the expansion of the market for antimicrobial resistance (AMR) genotyping panels. Antimicrobial-resistant infections are defined as illnesses caused by pathogens, including bacteria, viruses, fungi, or parasites, that have developed the ability to withstand the impact of conventional antimicrobial medications, thereby complicating treatment efforts. Widespread and improper utilization of antibiotics contributes significantly to the development of antimicrobial resistance. Such practices have expedited the appearance of resilient pathogens, consequently boosting the demand for AMR genotyping panels that enable swift identification of resistance genes and facilitate the administration of precise antimicrobial therapies. An illustration of this is the estimation by the Centers for Disease Control and Prevention (CDC) that over 2.8 million cases of antimicrobial-resistant infections manifest annually in the United States. Consequently, the escalating occurrence of these resistant infections is fueling the growth trajectory of the AMR genotyping panels market.
Antimicrobial Resistance (AMR) Genotyping Panels Market Segment Analysis And Revenue Opportunities
The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –
1) By Product Type: Custom Panels, Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies
3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users
Subsegments:
1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels
2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels
Antimicrobial Resistance (AMR) Genotyping Panels Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Key players within the antimicrobial resistance (AMR) genotyping panels market are prioritizing the creation of cutting-edge solutions, notably multiplex PCR-based research assays. These advanced tools are engineered to concurrently identify a variety of pathogens and genes conferring antibiotic resistance, thereby streamlining research endeavors and facilitating the rapid recognition of evolving resistance trends. Multiplex PCR-based research assays represent sophisticated molecular diagnostic techniques that amplify and simultaneously detect numerous genetic targets, allowing for the identification of both disease-causing organisms and genes associated with antibiotic resistance within a single analytical process. As an illustration, in September 2025, Molecular Designs, a prominent US-based entity specializing in molecular diagnostics and research assays, introduced the Urogenital Microbiota with ABX 53 Simplicity Panel. This particular multiplex PCR-based research assay was specifically developed for the simultaneous detection of urinary pathogens and antibiotic resistance genes. The panel facilitates the concurrent identification of 28 distinct microbial targets from the urogenital and urinary tracts (comprising 20 bacterial targets, 7 fungal targets, and 1 protozoan target), in conjunction with 25 markers for antibiotic resistance genes. Its design ensures same-day results and is available in both 96-well and 384-well plate configurations; furthermore, the 96-well format incorporates breakaway panels to minimize material wastage.
Antimicrobial Resistance (AMR) Genotyping Panels Market Leading Players Shaping Industry Direction
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
Access The Complete Antimicrobial Resistance (AMR) Genotyping Panels Market Report:
Antimicrobial Resistance (AMR) Genotyping Panels Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
